Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CXADR pseudogene 3 (CXADRP3) is a human pseudogene with sequence similarity to the CXADR gene, which encodes the Coxsackievirus and adenovirus receptor[1][5]. Pseudogenes like CXADRP3 are segments of DNA that resemble protein-coding genes but are generally viewed as non-functional; they typically arise from gene duplication or retrotransposition events and contain disabling mutations[1][5]. CXADRP3 does not encode a functional protein, is not known to function as a receptor, enzyme, transporter, or other molecular target, and is not a direct subject of drug interaction[1][5]. There is no established role for CXADRP3 in any canonical biological process or clinical condition. However, the broader class of pseudogenes, including other CXADR pseudogenes, has been shown to have diagnostic or regulatory potential in oncology research, as aberrant expression can sometimes distinguish cancer subtypes, though no such specific role is documented for CXADRP3[2]. CXADRP3 should not be confused with CXADR (Coxsackievirus and adenovirus receptor), which is a functional cell-surface receptor involved in viral entry, cell adhesion, and is a therapeutic target in virology and cardiology[3][4][6]. CXADRP3 is listed in major gene nomenclature databases as a validated human pseudogene at locus HGNC:33974[5]. If this query was intended to refer to the functional CXADR protein or receptor, the correct canonical form would be "Coxsackievirus and adenovirus receptor (CXADR)", not the pseudogene[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CXADR pseudogene 3 (CXADRP3).